Literature DB >> 10476001

Heparin-induced thrombocytopenia (HIT) due to heparin flushes: a report of three cases.

V V Kadidal1, D J Mayo, M K Horne.   

Abstract

Three cases of heparin-induced thrombocytopenia (HIT) are reported that were provoked by daily heparin flushes of central venous access devices. Each case had confounding features that delayed recognition of the problem. A review of the literature revealed only 29 previously reported cases of HIT secondary to heparin flushes. However, the true incidence of this problem is unknown. A high index of suspicion and confirmatory laboratory tests are necessary to make the diagnosis.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10476001     DOI: 10.1046/j.1365-2796.1999.00527.x

Source DB:  PubMed          Journal:  J Intern Med        ISSN: 0954-6820            Impact factor:   8.989


  10 in total

1.  Retention of lepirudin at the tip of a silicone catheter: a better catheter flush solution?

Authors:  McDonald K Horne; Elizabeth Inkellis
Journal:  Support Care Cancer       Date:  2004-02-13       Impact factor: 3.603

2.  Refractoriness to platelet transfusion in acute myeloid leukemia correlated with the optical density of anti-platelet factor 4/heparin antibodies.

Authors:  Mizuki Aimoto; Takahisa Yamane; Kazumasa Shiomoto; Chikahiko Sakamoto; Yasuhiro Nakashima; Hideo Koh; Takahiko Nakane; Yasunobu Takeoka; Asao Hirose; Mika Nakamae; Kiyoyuki Hagihara; Yoshiki Terada; Yoshitaka Nakao; Hirohisa Nakamae; Masayuki Hino; Shigeki Miyata
Journal:  Int J Hematol       Date:  2013-10       Impact factor: 2.490

Review 3.  Fundamental concepts in the pathobiology of heparin-induced thrombocytopenia.

Authors:  J L Januzzi; I K Jang
Journal:  J Thromb Thrombolysis       Date:  2000-11       Impact factor: 2.300

4.  Case studies in heparin-induced thrombocytopenia.

Authors:  A C Andreescu; M Cushman
Journal:  J Thromb Thrombolysis       Date:  2000-11       Impact factor: 2.300

5.  Heparin-induced thrombocytopenia in the pediatric population: a review of current literature.

Authors:  Niyati H Vakil; Abir O Kanaan; Jennifer L Donovan
Journal:  J Pediatr Pharmacol Ther       Date:  2012-01

6.  Thrombocytopenia caused by low-dose heparin supplementation of parenteral nutrition solution.

Authors:  Eunyoung Lee; Jeong-Ok Lee; Yoojoo Lim; Ji-Yeon Kim; Hyun Kyung Kim; Soo-Mee Bang
Journal:  Blood Res       Date:  2013-06-25

7.  Outcome of postoperative critically ill patients with heparin-induced thrombocytopenia: an observational retrospective case-control study.

Authors:  Elise M Gettings; Kathryn A Brush; Elizabeth M Van Cott; William E Hurford
Journal:  Crit Care       Date:  2006       Impact factor: 9.097

8.  Emphasis on the Role of PF4 in the Incidence, Pathophysiology and Treatment of Heparin Induced Thrombocytopenia.

Authors:  M Margaret Prechel; Jeanine M Walenga
Journal:  Thromb J       Date:  2013-04-05

9.  The use of fondaparinux for the treatment of venous thromboembolism in a patient with heparin-induced thombocytopenia and thrombosis caused by heparin flushes.

Authors:  Alex C Spyropoulos; Sharyl Magnuson; Sei Keng Koh
Journal:  Ther Clin Risk Manag       Date:  2008-06       Impact factor: 2.423

10.  Use of the Tego needlefree connector is associated with reduced incidence of catheter-related bloodstream infections in hemodialysis patients.

Authors:  Steven M Brunelli; Levi Njord; Abigail E Hunt; Scott P Sibbel
Journal:  Int J Nephrol Renovasc Dis       Date:  2014-04-03
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.